182 related articles for article (PubMed ID: 19564164)
21. Awareness is the name of the game: clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism.
Luder AS; Mamet R; Farbstein I; Schoenfeld N
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):19-22. PubMed ID: 19267997
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a commercially available rapid urinary porphobilinogen test.
Vogeser M; Stauch T
Clin Chem Lab Med; 2011 Sep; 49(9):1491-4. PubMed ID: 21627493
[TBL] [Abstract][Full Text] [Related]
23. [Anesthetic management of a patient with a history of acute intermittent porphyria and an elevation of urinary porphobilinogen].
Hiraki T; Oishi K; Kano T
Masui; 2001 Aug; 50(8):882-5. PubMed ID: 11554022
[TBL] [Abstract][Full Text] [Related]
24. A YOUNG GIRL WITH FITS.
Ahmed I; Ahmed E; Zaidi BH; Ansari JK; Nisar S
J Ayub Med Coll Abbottabad; 2015; 27(1):232-3. PubMed ID: 26182784
[TBL] [Abstract][Full Text] [Related]
25. [Porphyria. What to think in the absence of a cause of abdominal pain].
Bouizegarene P; Puy H; da Silva VP; Deybach JC
Rev Prat; 2010 Dec; 60(10):1341-4. PubMed ID: 21425523
[No Abstract] [Full Text] [Related]
26. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
Sardh E; Harper P; Andersson DE; Floderus Y
Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
[TBL] [Abstract][Full Text] [Related]
27. [Acute intermittent porphyria: actual problems of clinical and laboratory diagnosis].
Zelichowski G; Sosnowska A; Tymowicz J; Tutaj A; Wańkowicz Z
Pol Merkur Lekarski; 1998 Nov; 5(29):295-7. PubMed ID: 10101505
[TBL] [Abstract][Full Text] [Related]
28. [Effect of hematin in acute porphyric relapse].
Monsalve V; Wolff C; Gómez R; Armas Merino R; Canals C
Rev Med Chil; 1979 Jan; 107(1):38-41. PubMed ID: 462025
[No Abstract] [Full Text] [Related]
29. [Clinical and laboratory findings concerning at first dietary and afterwards cimetidine treatment of acute intermittent porphyria].
Gullotti D; Schillaci L; Amato S; Salerno L
Clin Ter; 1994 Aug; 145(8):123-9. PubMed ID: 7955957
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnostics of acute intermittent porphyria.
Kauppinen R
Expert Rev Mol Diagn; 2004 Mar; 4(2):243-9. PubMed ID: 14995910
[TBL] [Abstract][Full Text] [Related]
31. Yeast, creatinine and false diagnosis of porphyria.
Schoenfeld N; Sztern M; Mamet R
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):81-8. PubMed ID: 9074792
[TBL] [Abstract][Full Text] [Related]
32. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
Ulbrichova D; Hrdinka M; Saudek V; Martasek P
FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical features of acute intermittent porphyria: a retrospective analysis.
Mumoli N; Vitale J; Sabatini S; Cocciolo M; Gambaccini L; Masi L; Cei M
J Am Geriatr Soc; 2014 Sep; 62(9):1813-4. PubMed ID: 25243696
[No Abstract] [Full Text] [Related]
34. Clinical problem-solving. Still hazy after all these years.
Ben-Chetrit E; Putterman C
N Engl J Med; 1994 Oct; 331(14):934-8. PubMed ID: 7888006
[No Abstract] [Full Text] [Related]
35. [CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?].
Senn JD; Huber LC; Barman-Aksözen J; Minder E
Praxis (Bern 1994); 2018 Jan; 107(3):117-124. PubMed ID: 29382268
[No Abstract] [Full Text] [Related]
36. [The diagnosis and treatment of patients with acute intermittent porphyria].
Zakhariia EA; Romanishin IaN; Zastavnaia NA; Temnik IV; Antonenko SA; Kinakh MV; Grigorenko VV
Vrach Delo; 1991 Dec; (12):83-5. PubMed ID: 1792786
[TBL] [Abstract][Full Text] [Related]
37. [Porphyrin metabolic indices in the diagnosis of anemia in thalassemia].
Baĭtaeva DA; Abdullaev GM; Safarov IuI
Vrach Delo; 1982 Jan; (1):61-4. PubMed ID: 7072216
[No Abstract] [Full Text] [Related]
38. Mass spectrometric characterisation of a condensation product between porphobilinogen and indolyl-3-acryloylglycine in urine of patients with acute intermittent porphyria.
Marcos J; Ibañez M; Ventura R; Segura J; To-Figueras J; Pozo OJ
J Mass Spectrom; 2015 Jul; 50(7):929-37. PubMed ID: 26349648
[TBL] [Abstract][Full Text] [Related]
39. Measurement of urinary porphyrins and porphyrin precursors in Dutch hospital laboratories: a review of quality control over 5 years.
Zuijderhoudt FM; Weykamp CW; Willems HL
Ann Clin Biochem; 2003 Jul; 40(Pt 4):417-8. PubMed ID: 12880545
[TBL] [Abstract][Full Text] [Related]
40. [Acute intermittent porphyria and inappropriate ADH syndrome].
Tébar MT; Aguilera L
Rev Esp Anestesiol Reanim; 2010 May; 57(5):311-3. PubMed ID: 20527347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
